futureneuro的重点是解决慢性和罕见的神经疾病引起的社会经济负担。国际上以独特的方式,患者futureneuro神经疗法链接以创新的基因组和生物标志物为基础的分层,国家电子卫生保健的基础设施和全国性的临床网络的发展。 INITIALLY建立在世界领先的临床前和临床研究癫痫和发动机神经元疾病,futureneuro中心是一个可扩展的平台,将扩大专注于其他快速慢性和罕见的神经疾病。 futureneuro是相关的,在爱尔兰神经系统疾病的生物,具有相关的健康和社会成本大于每年€3十亿欧元70万人。欧元将加强爱尔兰吸引活跃在数万亿市场整体用于诊断,治疗企业对外直接投资和医药科技的神经系统疾病,和本土企业寻求促进获得ESTA市场的能力。

领导机构

外科医生在爱尔兰皇家学院(RCSI)

导向器

Prof David Henshall is Professor of Molecular Physiology & Neuroscience and has been working at the Royal College of Surgeons in Ireland since 2004. He was born in Germany but grew up in England, obtaining his undergraduate degree in pharmacology from the University of Bristol in 1994 and PhD in neuropharmacology from the University of Edinburgh in 1997. He then moved to the University of Pittsburgh, USA where he developed models to study how seizures affect the brain, later establishing his own laboratory at the Robert S. Dow Neurobiology laboratories in Portland, Ore in 1999. David’s research team is committed to improving the lives of people living with neurological disease, particularly epilepsy. By shedding light on the mechanisms underlying epilepsy, his work has led to discoveries informing on the treatment and diagnosis of the condition. Henshall has obtained >€10m in research funding and published over 150 scientific papers. He is the current President of Neuroscience Ireland.   

学术合作机构

共同PIS    

  • 教授gianpiero cavalleri,外科医生在爱尔兰皇家学院
  • 约亨Prehn教授,外科医生在爱尔兰皇家学院
  • 奥·哈迪曼教授,都柏林三一学院
  • 教授马修·坎贝尔,都柏林三一学院
  • 科林·多尔蒂博士,都柏林三一学院
  • 教授三丙沉,NUI戈尔韦